Home LiteratureArticle Details
PMID: 21054 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.

Clinical pharmacokinetics ·Vol. 2 ·No. 5 ·1977-00-00 ·Pages 373-83

Cunningham JL, Shen DD, Shudo I, Azarnoff DL

Abstract

To ascertain whether the renal clearance of disopyramide (pKa = 8.36) is affected by urine pH, the disposition kinetics of disopyramide were compared during excretion of acidic and alkaline urine following both single dose intravenous (2mg/kg) and oral (5 mg/kg) administration to 4 healthy male volunteers. No significant difference was observed in the plasma concentration-time curve of disopyramide. The mean 72 hour recovery of disopyramide and its N-deisopropyl metabolite (MND) in urine was 55.1 and 20.3% of the dose respectively, with no apparent difference between the two routes of administration or pH of urine. Renal clearance of disopyramide was found to vary with time, which is partly the result of a concentration dependent change in plasma protein binding. The unbound fraction of drug in plasma varied from 0.32 to 0.72 between 0.4 to 4microgram/ml concentration. However, time-dependent change in renal clearance of disopyramide persists even after correction for plasma protein binding.

MeSH Terms
Administration, Oral Adult Disopyramide/metabolism Half-Life Humans Hydrogen-Ion Concentration Injections, Intravenous Kidney/metabolism Male Protein Binding Pyridines/metabolism Urine
Chemicals
Pyridines Disopyramide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Cunningham J L
Shen D D
Shudo I
Azarnoff D L
References (21)
21 references, click to expand
  1. Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
    J Int Med Res. 1976;4(1 Suppl):54-8 PMID: 1026530
  2. Acute termination of cardiac arrhythmias with intravenous disopyramide.
    J Int Med Res. 1976;4(1 Suppl):82-5 PMID: 1026535
  3. Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine.
    J Chromatogr. 1975 Mar 19;106(1):151-8 PMID: 1150784
  4. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    J Int Med Res. 1976;4(1 Suppl):90-5 PMID: 1026537
  5. The pharmacokinetics of Norpace.
    Angiology. 1975 Jan;26(1 Pt 2):85-98 PMID: 1090217
  6. Circulatory effects of intravenous disopyramide in heart failure.
    J Int Med Res. 1976;4(1 Suppl):42-5 PMID: 1026527
  7. The use of disopyramide in the treatment of arrhythmias in ambulatory patients.
    J Int Med Res. 1976;4(1 Suppl):86-9 PMID: 1026536
  8. The influence of pH on the buccal absorption and renal excretion of disopyramide in man.
    Br J Clin Pharmacol. 1976 Aug;3(4):672-3 PMID: 22216514
  9. Haemodynamics of intravenous disopyramide.
    J Int Med Res. 1976;4(1 Suppl):46-8 PMID: 1026528
  10. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Lancet. 1976 Jan 10;1(7950):51-4 PMID: 54578
  11. Numerical solution of nonlinear pharmacokinetic equations: effects of plasma protein binding on drug distribution and elimination.
    J Pharm Sci. 1971 Nov;60(11):1623-8 PMID: 5133908
  12. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.
    J Pharmacokinet Biopharm. 1976 Jun;4(3):199-230 PMID: 978389
  13. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.
    J Int Med Res. 1976;4(1 Suppl):49-53 PMID: 1026529
  14. Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships II.
    J Pharm Sci. 1976 May;65(5):635-48 PMID: 6770
  15. Pharmacokinetic evidence for saturable renal tubular reabsorption of riboflavin.
    J Pharm Sci. 1970 Jun;59(6):765-72 PMID: 5463652
  16. Plasma protein binding of tricyclic anti-depressants in man.
    Biochem Pharmacol. 1969 Sep;18(9):2135-43 PMID: 5345888
  17. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
    J Int Med Res. 1976;4(1 Suppl):71-3 PMID: 799982
  18. Some pharmacological effects of disopyramide and a metabolite.
    J Int Med Res. 1976;4(1 Suppl):5-7 PMID: 193744
  19. The pharmacology of Norpace.
    Angiology. 1975 Jan;26(1 Pt 2):67-84 PMID: 1115403
  20. Effects of protein bindings of drugs on areas under plasma concentration--time curves.
    J Pharm Sci. 1972 Jan;61(1):138-9 PMID: 5058634
  21. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.
    J Pharm Sci. 1974 Nov;63(11):1684-90 PMID: 4427225
Article Info
Journal
Clinical pharmacokinetics
Abbr.
Clin Pharmacokinet
ISSN
0312-5963
Published
1977-00-00
Pages
373-83
Language
English
Region
Switzerland
NLM ID
7606849
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com